Composite hydrogel modulates regulatory T cell-mediated osteoimmunomodulatory osteogenesis for steroid-induced osteonecrosis of the femoral head
Source abstract
Abstract
• In this study, the regulation of regulatory T cells (T regs ) was used as a new target for repairing SONFH bone defects. • MS IL-2 /nHA@Gel CCL22 could release CCL22 and IL-2 to recruit and activate T regs , which improved the osteoimmune microenvironment in osteonecrotic regions and promoted macrophage M2 polarization, BMSCs osteogenic differentiation, and HUVECs vascularization. • In a rabbit SONFH model, MS IL-2 /nHA@Gel CCL22 mobilized T reg homing and aided femoral head repair. Steroid-induced osteonecrosis of the femoral head (SONFH) is a prevalent condition in clinical settings, often leading to femoral head collapse without timely intervention, necessitating total hip arthroplasty (THA). However, THA carries significant financial costs and substantial risks. Drilling and decompression combined with autologous bone grafting are widely utilized to treat early-stage SONFH. Nevertheless, the drawbacks of autologous bone graft harvesting limit its clinical utility. Many studies have sought to replace autologous grafts with biomaterials to mitigate these adverse effects. However, the role of regulatory T cells (T regs ) in the osteonecrotic region is often ignored. The reduced quantity and impaired function of T regs in the osteonecrotic region hinder the T reg -mediated osteogenic differentiation of BMSCs and M2 polarization of macrophages, disrupting the immune microenvironment and stalling bone repair. We prepared an injectable functionalized hydrogel (MS IL-2 /nHA@Gel CCL22 ), capable of releasing CCL22 and IL-2 to recruit T regs , and activate them via the JAK3/STAT5/Foxp3 pathway. This intervention promoted macrophage M2 polarization, osteogenic differentiation of BMSCs, and vascularization of HUVECs. In a rabbit SONFH model, implantation of MS IL-2 /nHA@Gel CCL22 successfully mobilized T reg homing, stimulated osteogenesis and angiogenesis, and facilitated femoral head repair. In summary, MS IL-2 /nHA@Gel CCL22 effectively recruits and activates T regs , enhancing osteoimmunomodulatory processes to repair SONFH.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone and Joint Diseases · Orthopaedic implants and arthroplasty · Spondyloarthritis Studies and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Bioengineering strategies targeting angiogenesis: innovative solutions for osteonecrosis of the femoral head10.1177/20417314241310541 ↗
2. Nontraumatic osteonecrosis of the femoral head: where do we stand today?: A 5-year update10.2106/JBJS.19.01271 ↗
3. Effect of patient age on total hip arthroplasty outcomes in patients who have osteonecrosis of the femoral head compared to patients who have hip osteoarthritis10.1016/j.arth.2023.12.029 ↗
4. D. Zhao, F. Zhang, B. Wang, B. Liu, L. Li, S.Y. Kim, S.B. Goodman, P. Hernigou, Q. Cui, W.C. Lineaweaver, J. Xu, W.R. Drescher, L. Qin, Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version), J Orthop Translat 21 (2020) 100-110.10.1016/j.jot.2019.12.004 ↗
5. Advances in experimental models of osteonecrosis of the femoral head10.1016/j.jot.2023.01.003 ↗
6. Does osteonecrosis of the femoral head increase early complication rates after total hip arthroplasty? A Japanese nationwide medical claims database study10.1016/j.arth.2025.01.029 ↗
7. J. Yang, P. Sun, Z. Liu, Y. Li, J. Zhang, Y. Liu, G. Zou, Mid-term Clinical Outcomes of “Light Bulb” Core Decompression with Arthroscopic Assistance in Peri-collapse Osteonecrosis of the Femoral Head: A Retrospective Comparative Study, 16(6) (2024) 1399-1406.10.1111/os.14058 ↗
8. Thermoresponsive dual-network chitosan-based hydrogels with demineralized bone matrix for controlled release of rhBMP9 in the treatment of femoral head osteonecrosis10.1016/j.carbpol.2024.123197 ↗
9. Biofunctionalized composite scaffold to potentiate osteoconduction, angiogenesis, and favorable metabolic microenvironment for osteonecrosis therapy
10. The interactions of macrophages, lymphocytes, and mesenchymal stem cells during bone regeneration10.1302/2046-3758.139.BJR-2024-0122.R1 ↗
11. Stimuli-responsive hydrogel with spatiotemporal co-delivery of FGF21 and H2S for synergistic diabetic wound repair10.1016/j.jconrel.2025.113749 ↗
12. Clinical immunity in bone and joints10.1007/s00774-018-0965-5 ↗
13. A. Unterman, A.Y. Zhao, Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis, 210(4) (2024) 484-496.10.1164/rccm.202306-0979OC ↗
14. Effects of interleukin-2 in immunostimulation and immunosuppression10.1084/jem.20191247 ↗
15. Dopamine-functionalized chondroitin sulfate/gelatin-based composite hydrogels for enhancing wound healing and bone regeneration10.1016/j.carbpol.2025.123809 ↗
16. Investigating the role of amino acids in short peptides for hydroxyapatite binding and osteogenic differentiation of mesenchymal stem cells to aid bone regeneration10.1021/acs.biomac.3c01148 ↗
17. Engineering large-scale self-mineralizing bone organoids with bone matrix-inspired hydroxyapatite hybrid bioinks10.1002/adma.202470239 ↗
18. X. Li, X. Li, J. Yang, J. Lin, Y. Zhu, X. Xu, Living and Injectable Porous Hydrogel Microsphere with Paracrine Activity for Cartilage Regeneration, 19(17) (2023) e2207211.10.1002/smll.202207211 ↗
19. Delivery of MiR335-5p-pendant tetrahedron DNA nanostructures using an injectable heparin lithium hydrogel for challenging bone defects in steroid-associated osteonecrosis10.1002/adhm.202101412 ↗
20. An injectable self-adaptive polymer as a drug carrier for the treatment of nontraumatic early-stage osteonecrosis of the femoral head10.1038/s41413-022-00196-y ↗
21. Efficiency of cell therapy to GC-induced ONFH: BMSCs with Dkk-1 interference is not superior to unmodified BMSCs10.1155/2018/1340252 ↗
22. Nanofibrous spongy microspheres to distinctly release miRNA and growth factors to enrich regulatory T cells and rescue periodontal bone loss10.1021/acsnano.7b08976 ↗
23. Immunomodulatory dual-sized microparticle system conditions human antigen presenting cells into a tolerogenic phenotype in vitro and inhibits type 1 diabetes-specific autoreactive T cell responses10.3389/fimmu.2020.574447 ↗
24. A pH/H(2) O(2) /MMP9 time-response gel system with Sparc(high) Tregs derived extracellular vesicles promote recovery after acute myocardial infarction10.1002/adhm.202200971 ↗
25. Microneedle‐based local delivery of CCL22 and IL‐2 enriches Treg Homing to the skin allograft and enables temporal monitoring of immunotherapy efficacy
26. Polydopamine nanoparticle-mediated dopaminergic immunoregulation in colitis
27. Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T(reg) reduction and effector T cell activation10.1126/sciimmunol.abn8097 ↗
28. B. Gong, Y. Liu, A Silk Fibroin Nanoparticle Hydrogel Loaded With NK1R Antagonist Has Synergistic Anti-Inflammatory and Reparative Effects on Dry Eye Disease, 12(15) (2025) e2404835.10.1002/advs.202404835 ↗
29. Facile fabrication of a biocompatible composite gel with sustained release of aspirin for bone regeneration
30. Treg-tissue cell interactions in repair and regeneration
31. The ‘Treg paradox’ in inflammatory arthritis10.1038/s41584-024-01190-w ↗
32. Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity10.1016/j.immuni.2024.07.010 ↗
33. The role of transcription factors in shaping regulatory T cell identity10.1038/s41577-023-00893-7 ↗
34. Progranulin-dependent repair function of regulatory T cells drives bone-fracture healing10.1172/JCI180679 ↗
35. Biphasic calcium phosphate recruits Tregs to promote bone regeneration10.1016/j.actbio.2024.01.001 ↗
36. The role of immune regulatory cells in nontraumatic osteonecrosis of the femoral head: a retrospective clinical study10.1155/2019/1302015 ↗
37. Context-dependent effect of glucocorticoids on the proliferation, differentiation, and apoptosis of regulatory T cells: a review of the empirical evidence and clinical applications10.3390/ijms20051142 ↗
38. Immunomodulatory effects of dexamethasone on gene expression of cytokine and stress hormone receptors in peripheral blood mononuclear cells10.1016/j.intimp.2013.07.019 ↗
39. Regulatory and effector T-cells are differentially modulated by Dexamethasone10.1016/j.clim.2013.09.008 ↗